ViBone Moldable, provided by Aziyo Biologics, is a next-generation viable cell bone matrix optimized to protect and preserve the health of native bone cells.
ALLOB will be applied by a single injection up to 4 days post-reduction surgery in patients with fresh tibial fractures at risk for delayed or non-union.
The company has completed recruitment and treated all patients in its Phase III study with the viscosupplement, JTA-004, in patients with knee osteoarthritis.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more